McKesson - MCK Stock Forecast, Price & News

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Analyst Ratings Changes

A number of equities research analysts have recently commented on the stock. Cowen upped their target price on shares of McKesson from $325.00 to $361.00 and gave the company an "outperform" rating in a report on Monday, April 18th. Robert W. Baird increased their price target on shares of McKesson from $386.00 to $400.00 and gave the company an "outperform" rating in a research report on Thursday. UBS Group increased their price target on shares of McKesson from $380.00 to $400.00 and gave the company a "buy" rating in a research report on Thursday. Deutsche Bank Aktiengesellschaft upgraded shares of McKesson from a "hold" rating to a "buy" rating and increased their price target for the company from $343.00 to $378.00 in a research report on Tuesday, June 7th. Finally, Morgan Stanley raised their target price on shares of McKesson from $292.00 to $370.00 and gave the stock an "overweight" rating in a research report on Tuesday, April 12th. Two analysts have rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $333.46.

McKesson Trading Down 0.2 %

NYSE:MCK traded down $0.55 during trading on Monday, hitting $346.14. 24,399 shares of the company traded hands, compared to its average volume of 1,157,015. McKesson has a 12 month low of $192.38 and a 12 month high of $348.49. The business has a fifty day simple moving average of $324.08 and a 200 day simple moving average of $306.90. The company has a market capitalization of $49.70 billion, a P/E ratio of 36.81, a PEG ratio of 1.43 and a beta of 0.63.

McKesson (NYSE:MCK - Get Rating) last released its earnings results on Thursday, May 5th. The company reported $5.83 earnings per share for the quarter, missing analysts' consensus estimates of $6.06 by ($0.23). The firm had revenue of $66.10 billion for the quarter, compared to analyst estimates of $63.82 billion. McKesson had a negative return on equity of 350.22% and a net margin of 0.52%. The firm's quarterly revenue was up 11.8% compared to the same quarter last year. During the same period last year, the business earned $5.05 earnings per share. Equities research analysts predict that McKesson will post 24.33 EPS for the current fiscal year.

McKesson Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, October 3rd. Shareholders of record on Thursday, September 1st will be given a dividend of $0.54 per share. This is a boost from McKesson's previous quarterly dividend of $0.47. The ex-dividend date of this dividend is Wednesday, August 31st. This represents a $2.16 annualized dividend and a dividend yield of 0.62%. McKesson's payout ratio is presently 19.87%.

Insider Activity

In other news, CEO Brian S. Tyler sold 8,678 shares of the stock in a transaction dated Wednesday, May 11th. The shares were sold at an average price of $331.45, for a total transaction of $2,876,323.10. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other McKesson news, CEO Brian S. Tyler sold 8,678 shares of the stock in a transaction that occurred on Wednesday, May 11th. The shares were sold at an average price of $331.45, for a total transaction of $2,876,323.10. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Brian S. Tyler sold 3,232 shares of the stock in a transaction that occurred on Monday, June 13th. The stock was sold at an average price of $308.31, for a total transaction of $996,457.92. Following the sale, the chief executive officer now owns 82,039 shares in the company, valued at approximately $25,293,444.09. The disclosure for this sale can be found here. Insiders sold 67,190 shares of company stock valued at $21,980,148 in the last quarter. Company insiders own 0.21% of the company's stock.